Eli Lilly’s “triple g” drug helped patients lose about 28.7% of their body weight while also reducing pain associated with ...

Pacira ($PCRX) announced an update on their ongoing clinical study. Study Overview: Pacira Pharmaceuticals is running a Phase 2 trial titled “A ...

SereNeuro Therapeutics revealed promising results for SN101, a first-in-class iPSC-derived therapy designed to treat chronic ...

Rutgers Health experts have expanded treatment options for knee osteoarthritis, a condition caused by the gradual breakdown ...

Osteoarthritis (OA) remains one of the leading causes of disability worldwide, burdening health systems and diminishing quality of life ...

The PPV-06 vaccine was safe, immunogenic, and linked with functional improvement at 42 weeks in a phase 1 trial of inflammatory knee osteoarthritis.

Knee osteoarthritis pain can be eased without surgery or medication. Researchers are exploring gait training, a method to ...

Transcutaneous auricular vagus nerve stimulation demonstrates safety and potential benefits in patients with erosive hand ...

A new study has found the non-invasive application of in-ear electrical stimulation to the vagus nerve to be safe and effective in reducing osteoarthritis-related knee pain. It opens the door to ...

Most people with knee osteoarthritis can control their pain and improve their mobility without surgery, according to updated treatment guidelines from the Australian Commission on Safety and Quality ...

Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the Phase 3 TRIUMPH-4 clinical trial ...

A generic product for managing pain and inflammation associated with osteoarthritis (OA) in canines has been approved by FDA ...